Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.87 |
| ▸ | MAOA | P21397 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.52 |
| ▸ | MAPT | P10636 | 6/20 | 0.52 |
| ▸ | RAB9A | P51151 | 6/20 | 0.52 |
| ▸ | NPC1 | O15118 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | PTPRC | P08575 | 2/20 | 0.52 |
| ▸ | APAF1 | O14727 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | S100A4 | P26447 | 2/20 | 0.52 |
| ▸ | GALK1 | P51570 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17899750 | 1.00 | ELANE (0.87) | ELANEMAOAMAOBKMT2AMEN1 | |
| SCHEMBL16656188 | 0.95 | ELANE (0.79) | ELANEMAOAMAOBKMT2AMEN1 | |
| SCHEMBL354335 | 0.95 | ELANE (0.95) | ELANEMAOAMAOBKMT2AMEN1 | |
| SCHEMBL30419213 | 0.95 | ELANE (0.95) | ELANEMAOAMAOBKMT2AMEN1 | |
| Tectoquinone SCHEMBL36822 | 0.93 | ELANE (1.00) | ELANEMAOAMAOBKMT2AMEN1 | |
| Tectoquinone SCHEMBL2444159 | 0.93 | ELANE (1.00) | ELANEMAOAMAOBKMT2AMEN1 | |
| Tectoquinone SCHEMBL29403487 | 0.93 | ELANE (1.00) | ELANEMAOAMAOBKMT2AMEN1 | |
| Tectoquinone SCHEMBL30618448 | 0.93 | ELANE (1.00) | ELANEMAOAMAOBKMT2AMEN1 | |
| Tectoquinone SCHEMBL28051910 | 0.93 | ELANE (1.00) | ELANEMAOAMAOBKMT2AMEN1 | |
| SCHEMBL6036732 | 0.91 | ELANE (0.87) | ELANEMAOAMAOBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115528215-A | Secondary battery positive electrode material pre-ionization reagent and preparation method and application thereof | 深圳珈钠能源科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| US-20240360319-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | BioLegend, Inc. | 2024-10-31 | — | — | US | disclosed |
| US-12091554-B2 | Substituted polyfluorene compounds | BioLegend, Inc. (US) | 2024-09-17 | — | — | US | disclosed |
| CN-113365971-B | Compound and light-emitting element using same | 住友化学株式会社 | 2024-04-30 | — | — | CN | disclosed |
| US-11917913-B2 | Substituted oxepines | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11917913-B2 | Substituted oxepines | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-20230002555-A1 | TRIAZINE RING-CONTAINING POLYMER AND FILM FORMING COMPOSITION CONTAINING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| CN-115528215-A | Secondary battery positive electrode material pre-ionization reagent and preparation method and application thereof | 深圳珈钠能源科技有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-113652705-B | Method for synthesizing fluorenone through catalytic electrolysis of N-hydroxyphthalimide | 北京工业大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20220123220-A1 | COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20080200736-A1 | MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080200736-A1 | MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080194590-A1 | 4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors | PFIZER INC | 2008-08-14 | — | — | US | disclosed |
| US-7399577-B2 | Halogenated oxime derivatives and the use thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-07-15 | — | — | US | disclosed |
| US-7399577-B2 | Halogenated oxime derivatives and the use thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-07-15 | — | — | US | disclosed |
| US-20070059364-A1 | Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 2007-03-15 | — | — | US | disclosed |
| US-20070059364-A1 | Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 2007-03-15 | — | — | US | disclosed |
| WO-2001009117-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELLIX NEUROSCIENCE INC. (US) | 2001-02-08 | — | — | WO | disclosed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |
| EP-0886182-A1 | Positive photoresist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200736-A1 | MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME | LEF1, FMNL1, AFF1 | ELANE 767/4885MAOA 717/4885MAOB 924/4885 |
| US-20070059364-A1 | Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity | HTR6, NPY5R, NPY2R | ELANE 2736/4885MAOA 136/4885MAOB 197/4885 |
| US-11917913-B2 | Substituted oxepines | OXGR1, OXTR, OCIAD2 | ELANE 1010/4885MAOA 161/4885MAOB 446/4885 |
| US-20220123220-A1 | COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | NR2E3, CRY1, GRK1 | ELANE 974/4885MAOA 1391/4885MAOB 1620/4885 |
| US-20080194590-A1 | 4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors | PFKP, PF4, P2RY4 | ELANE 1923/4885MAOA 1106/4885MAOB 1020/4885 |
| US-20240360319-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | PARG, PFAS, PARN | ELANE 1023/4885MAOA 1268/4885MAOB 1458/4885 |
| US-12091554-B2 | Substituted polyfluorene compounds | PARG, PFAS, PARN | ELANE 1023/4885MAOA 1268/4885MAOB 1458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.